Since nonmelanoma skin "cancer" usually poses no threat at all to survival, the reason to treat the "cancer" is to improve well being. ? ?We can enhance well being by treating a "cancer" that is currently bothersome to the patient, or will become bothersome if it grows and expands.? But this is where it gets interesting.? Since many of these "cancers" grow very slowly, some will never become problematic in the patient's lifetime.? This is a very important consideration as skin "cancer" is predominantly a disease of older people.? Many persons with skin "cancer" are very old or very frail.? Patients with limited life expectancies may do fine with either minimal treatment, or perpaps even no treatment at all.? This suggests that the best treatment for a particular "cancer" needs to consider the age and health status of the patient.?
But, in actual practice, when a patientt has skin "cancer", does the treating provider consider the individual characteristics of the patient in front of them, or do they use a one size fits all approach, focusing on the "cancer", but not the person?
A fascinating study in JAMA Internal Medicine suggests we are overtreating skin "cancer" in patients who are very old or very frail because of a one size fits all approach to treatment.? The study was led by Dr. Eleni Linos, with senior author Dr. Mary-Margaret Chren, both Dermatologists at UCSF.? They examined treatment of patients with nonmelanoma skin "cancer" at UCSF and the San Francisco VA.? They did a very interesting comparison of how skin "cancer" treatment varied in patients with long vs limited life expectancies.? The limited life expectancy group included persons over the age of 85, or with many medical conditions.?
They found:
- Patients are almost always treated.? The no treatment option was chosen for only 3% of skin "cancers". ?Of note, 60% of "cancers" were not on the face, and in only 22% of cases were patients significantly bothered by their "cancer", suggesting that very conservative management of deferred treatment should have been reasonable in at least some patients.
- Patient characteristics are not considered in the treatment decision. ?There are a number of treatment options for patients ranging from very simple and less invasive options like destruction (i.e., freezing) to surgical options. ?The most invasive option, Moh's surgery was used in 34% of patients. ?Moh's surgery takes on average 3 hours and is also the most expensive option. ?Patients with long life expectancies and short life expectancies were equally likely to get Moh's surgery. ?Thus very advanced age or severe co-existing disease seemed to make not one iota of difference in treatment.?
by: Ken Covinsky (@geri_doc)
Source: http://www.geripal.org/2013/05/are-older-persons-being-over-treated.html
Suspects in Boston Bombing Kerry Rhodes Daft Punk Get Lucky Texas explosion Paul Kevin Curtis man of steel man of steel
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.